Oxford Biomedica (OTCMKTS:OXBDF – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “Oxford BioMedica Plc is a gene and cell therapy company which focused on developing life changing treatments for serious diseases. Oxford […]
Equities Research Analysts’ upgrades for Friday, May 27th: Atlas Air Worldwide (NASDAQ:AAWW) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. AutoNation (NYSE:AN) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Auto Trader Group (OTCMKTS:ATDRY) was upgraded by analysts at JPMorgan Chase & Co. […]
Allogeneic Cell Therapy Manufacturing Market Research Insight 2022| Industry Development – Growth Opportunities in Future, Revenue Forecast Up to 203